RBC Capital analyst Nik Modi maintained a Hold rating on Clorox (CLX – Research Report) yesterday and set a price target of $143.00. The company’s shares closed yesterday at $147.78.
According to TipRanks, Modi is a 5-star analyst with an average return of 6.4% and a 60.32% success rate. Modi covers the Consumer Defensive sector, focusing on stocks such as Clorox, Constellation Brands, and The Hershey Company.
Currently, the analyst consensus on Clorox is a Hold with an average price target of $150.36, which is a 1.75% upside from current levels. In a report released on April 17, Deutsche Bank also maintained a Hold rating on the stock with a $151.00 price target.
Based on Clorox’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.99 billion and a net profit of $93 million. In comparison, last year the company earned a revenue of $1.72 billion and had a net profit of $99 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Clorox (CLX) Company Description:
Founded in 1913, California-based The Clorox Co. manufactures and markets consumer and professional products. It operates through four business segments: Health and Wellness, Household, Lifestyle, and International.
Read More on CLX:
